Search Results - Jurcic, J.G

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Ab therapy of AML: native anti-CD33 Ab and drug conjugates

    Ab therapy of AML: native anti-CD33 Ab and drug conjugates by Jurcic, J.G., MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P-290 Phase 2 study of decitabine in combination with tretinoin in myelodysplastic syndromes and acute myelogenous leukemia

    P-290 Phase 2 study of decitabine in combination with tretinoin in myelodysplastic syndromes and acute myelogenous leukemia by Klimek, V, Dolezal, E.D, Jurcic, J.G, Devlin, S, Zikaras, K, Park, J.H, Rosenblat, T.L, Nimer, S.D

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    179 Phase 1/2 study of decitabine in combination with tretinoin in myelodysplastic syndromes: Interim results

    179 Phase 1/2 study of decitabine in combination with tretinoin in myelodysplastic syndromes: Interim results by Klimek, V.M, Dolezal, E.K, Ryan, C, Jurcic, J.G, Nimer, S.D

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Targeted Alpha-particle Nano-generator Actinium-225 (225 Ac)-lintuzumab (anti-CD33) in Acute Myeloid Leukemia (AML)

    Targeted Alpha-particle Nano-generator Actinium-225 (225 Ac)-lintuzumab (anti-CD33) in Acute Myeloid Leukemia (AML) by Jurcic, J.G, Rosenblat, T.L, McDevitt, M.R, Pandit-Taskar, N, Carrasquillo, J.A, Chanel, S.M, Zikaras, K, Frattini, M.G, Maslak, P.M, Cicic, D, Larson, S.M, Scheinberg, D.A

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: